Latest Breaking News On - பால் பெடர்ஸெந் - Page 8 : comparemela.com
Nextleaf Solutions Ltd granted another US patent as it applies for dealer s license in Canada
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Nextleaf Awarded U S Patent and Engages CannDelta for Psychedelics Dealer s Licence
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Nextleaf Solutions launches Specialty Molecules Division to leverage IP portfolio
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
NA Proactive news snapshot: Spotlite360 Technologies, BioHarvest Sciences, Kainantu Resources, KushCo Holdings, Nextleaf Solutions UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Spotlite360 Technologies Inc (CSE:LITE), the logistics technologies developer, debuted its shares on the Canadian Securities Exchange on June 15. Shares of the Denver- and Vancouver-based company are trading under the ticker symbol ‘LITE.’ The listing follows Spotlite360’s recent acquisition of Captios LLC, a supply chain innovator, which is now a wholly owned subsidiary of the company.
BioHarvest Sciences Inc (CSE:BHSC) (OTCMKTS:CNVCF) (FRA:8MV) has said that VINIA, its red grape cell functional food, is the “only dietary supplement in the US market” which reduces the endothelin 1 (ET1) enzyme, and increases the nitric oxide (NO) molecules, in order to “increase the dilation
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development
News provided by
Share this article
Financialnewsmedia.com News Commentary
PALM BEACH, Fla., June 15, 2021 /PRNewswire/ The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get to the people who need them the most, they must pass through the extensive drug development pipeline, where IP & Patents are crucial. It seems that a week doesn t go by without a psychedelic company saying it has filed for a new patent. An informative article on Microdose explains the reasons why psychedelic companies are pursuing these patents. First, the plants that the medicines are based on can t be patented. Products in nature belong to the public and thus can t be patented. Microdose wrote, One company cannot claim it as intellectual property to exclusively profit from it. How